Fluticasone Furoate Chemical Structure (Fluticasone Furoate Ellipta Spl Graphic 01)
Fluticasone Furoate Ellipta Powder
Product Images NDC 66993-166
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Fluticasone Furoate Ellipta (NDC 66993-166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Fluticasone Furoate Ellipta Spl Graphic 02)
This text provides population description data for a study or research project. It includes information on age group (>65 years), gender distribution (male), renal impairment severity (severe), hepatic impairment severity (mild, moderate, severe), and fold change with a confidence interval. Recommendations for dose adjustments are also outlined, including cautions for certain scenarios.*
Figure 2 (Fluticasone Furoate Ellipta Spl Graphic 03)
This text provides recommendations on the interaction of the drug Ketoconazole with PK Fold Change and 90% Confidence Interval. The table shows the fold change of AUC and Crmax at various values along with the corresponding recommendations ranging from caution to specific values.*
Figure 3 (Fluticasone Furoate Ellipta Spl Graphic 04)
The text provides a comparison of differences from placebo and 95% confidence intervals for multiple trials and treatment doses. It includes data points such as '0.5', '0.4', '0.3', '0.2', '0.1', '0.0' across various trials denoted by trial numbers like 687, 685, and 684. Additionally, it lists different treatment doses in micrograms, such as 100, 200, 300, 400, and 500. The text seems to be part of a statistical analysis or clinical trial results, showing how various treatments compare to a placebo with confidence intervals.*
Figure 4 (Fluticasone Furoate Ellipta Spl Graphic 05)
Figure 5 (Fluticasone Furoate Ellipta Spl Graphic 06)
Figure 6 (Fluticasone Furoate Ellipta Spl Graphic 07)
This is a comparison of LS mean change from baseline in milliliters at different time points after taking Fluticasone Furoate ELIPTA 200 mcg once daily versus Fluticasone Propionate 500 mcg twice daily. The time points evaluated are at 6, 12, 18, 20, 22, and 24 hours post-dose.*
Fluticasone Furoate Ellipta Inhaler (Fluticasone Furoate Ellipta Spl Graphic 08)
Figure A (Fluticasone Furoate Ellipta Spl Graphic 09)
Figure B (Fluticasone Furoate Ellipta Spl Graphic 10)
Figure C (Fluticasone Furoate Ellipta Spl Graphic 11)
Figure D (Fluticasone Furoate Ellipta Spl Graphic 12)
Figure E (Fluticasone Furoate Ellipta Spl Graphic 13)
Figure F (Fluticasone Furoate Ellipta Spl Graphic 14)
Figure G (Fluticasone Furoate Ellipta Spl Graphic 15)
Figure H (Fluticasone Furoate Ellipta Spl Graphic 16)
Figure I (Fluticasone Furoate Ellipta Spl Graphic 17)
Figure J (Fluticasone Furoate Ellipta Spl Graphic 18)
Figuer K (Fluticasone Furoate Ellipta Spl Graphic 19)
Figure L (Fluticasone Furoate Ellipta Spl Graphic 20)
Fluticasone Furoate 50mcg 30 Dose Carton (Fluticasone Furoate Ellipta Spl Graphic 21)
This is a description for Fluticasone Furoate ELLIPTA Inhalation Powder at a concentration of 50 mcg for oral inhalation use. Each blister contains 50 mcg of fluticasone furoate and lactose monohydrate. The product comes in an ELLIPTA Inhaler with 1 foil strip containing 30 blisters.*
Fluticasone Furoate 100mcg 30 Dose Carton (Fluticasone Furoate Ellipta Spl Graphic 22)
This is a description of Fluticasone furoate ELLIPTA inhalation powder medication. Each blister contains 100 micrograms of fluticasone furoate and lactose monohydrate. The medication is for oral inhalation only and comes in an ELLIPTA inhaler containing one foil strip with 30 blisters. This product is available by prescription only.*
Fluticasone Furoate 200mcg 30 Dose Carton (Fluticasone Furoate Ellipta Spl Graphic 23)
This is a medication called Fluticasone Furoate ELLIPTA Inhalation Powder at a strength of 200 mcg. It is designed for oral inhalation use only. Each blister contains 200 mcg of Fluticasone Furoate and lactose monohydrate. The package includes one ELLIPTA inhaler with one foil strip containing 30 blisters. This medication is available by prescription only.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
